Chemours finds material weaknesses after internal review (NYSE:CC)

JHVEPhoto

Chemours (NYSE:CC) stock on Wednesday slid nearly 11% in extended trading, after the chemical manufacturer finally filed its twice-delayed annual report which showed a smaller loss for Q4 2023 and said its internal review had found “material weaknesses” in its financial reporting.

The post Chemours finds material weaknesses after internal review (NYSE:CC) first appeared on Investorempires.com.

 

Default Featured Image

Trans Mountain pipeline project faces new delay on technical issues (OTCMKTS:MEGEF) | Investorempires.com

Read More | ImagineGolf/E+ via Getty Images The long-delayed project to expand Canada’s Trans Mountain pipeline has been hit with another setback, which will delay completion of the project to Q2 at the earliest, the company said Monday. The government-owned pipeline operator said it encountered technical issues during January 25-27 involving activity with one of […]